Intuitive Surgical, Inc. (BKK:ISRG01)

Market Cap	5.57T -19.9%
Revenue (ttm)	317.41B +20.5%
Net Income	90.07B +23.0%
EPS	248.20 +22.6%
Shares Out	n/a
PE Ratio	61.90
Forward PE	49.39
Dividend	n/a
Ex-Dividend Date	n/a

Volume	151,116
Average Volume	191,204
Open	3.460
Previous Close	3.480
Day's Range	3.440 - 3.500
52-Week Range	3.280 - 4.120
Beta	n/a
RSI	35.87
Earnings Date	Apr 14, 2026

About Intuitive Surgical

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling,...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1995
• Employees: 17,021
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: ISRG01

Financial Performance

In 2025, Intuitive Surgical's revenue was $10.06 billion, an increase of 20.51% compared to the previous year's $8.35 billion. Earnings were $2.86 billion, an increase of 22.97%.

Financial numbers in USD